Aerie Pharmaceuticals, Inc.

Home » Aerie Pharmaceuticals, Inc.

Secondary

Aerie Pharmaceuticals, Inc.

They are an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma or ocular hypertension and other diseases of the eye.

Symbol

AERI

Last Closing Price
$61.00

Shares
1,300,000

Effective Date
January 24, 2018

Underwriters
Cantor Fitzgerald

To view the prospectus for Aerie Pharmaceuticals, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253